BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gibson-Corley KN, Meyerholz DK, Engelhardt JF. Pancreatic pathophysiology in cystic fibrosis. J Pathol 2016;238:311-20. [PMID: 26365583 DOI: 10.1002/path.4634] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Cutting GR, Engelhardt J, Zeitlin PL. Genetics and Pathophysiology of Cystic Fibrosis. Kendig's Disorders of the Respiratory Tract in Children. Elsevier; 2019. pp. 757-768.e6. [DOI: 10.1016/b978-0-323-44887-1.00049-3] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Soares VEM, do Carmo TIT, Dos Anjos F, Wruck J, de Oliveira Maciel SFV, Bagatini MD, de Resende E Silva DT. Role of inflammation and oxidative stress in tissue damage associated with cystic fibrosis: CAPE as a future therapeutic strategy. Mol Cell Biochem 2021. [PMID: 34529223 DOI: 10.1007/s11010-021-04263-6] [Reference Citation Analysis]
3 Konrad J, Eber E, Stadlbauer V. Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators. Paediatr Respir Rev 2020:S1526-0542(20)30181-0. [PMID: 33485777 DOI: 10.1016/j.prrv.2020.12.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bhandari R, Gupta S, Modi K, Raval MR, Joundi H, Patel JR, Pannu AK, Sharma P. Persistent Cannabis Abuse and Risk for Hospitalization for Acute Pancreatitis: A Cross-Sectional Study in United States Hospitals. Cureus 2021;13:e15601. [PMID: 34277222 DOI: 10.7759/cureus.15601] [Reference Citation Analysis]
5 Terlizzi V, Amato F, Castellani C, Ferrari B, Galietta LJV, Castaldo G, Taccetti G. Ex vivo model predicted in vivo efficacy of CFTR modulator therapy in a child with rare genotype. Mol Genet Genomic Med 2021;9:e1656. [PMID: 33713579 DOI: 10.1002/mgg3.1656] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Lin YC, Keenan K, Gong J, Panjwani N, Avolio J, Lin F, Adam D, Barrett P, Bégin S, Berthiaume Y, Bilodeau L, Bjornson C, Brusky J, Burgess C, Chilvers M, Consunji-Araneta R, Côté-Maurais G, Dale A, Donnelly C, Fairservice L, Griffin K, Henderson N, Hillaby A, Hughes D, Iqbal S, Itterman J, Jackson M, Karlsen E, Kosteniuk L, Lazosky L, Leung W, Levesque V, Maille É, Mateos-Corral D, McMahon V, Merjaneh M, Morrison N, Parkins M, Pike J, Price A, Quon BS, Reisman J, Smith C, Smith MJ, Vadeboncoeur N, Veniott D, Viczko T, Wilcox P, van Wylick R, Cutting G, Tullis E, Ratjen F, Rommens JM, Sun L, Solomon M, Stephenson AL, Brochiero E, Blackman S, Corvol H, Strug LJ. Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth. Genet Med 2021;23:927-33. [PMID: 33500570 DOI: 10.1038/s41436-020-01073-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hermes WA, Alvarez JA, Lee MJ, Chesdachai S, Lodin D, Horst R, Tangpricha V. Prospective, Randomized, Double-Blind, Parallel-Group, Comparative Effectiveness Clinical Trial Comparing a Powder Vehicle Compound of Vitamin D With an Oil Vehicle Compound in Adults With Cystic Fibrosis. JPEN J Parenter Enteral Nutr 2017;41:952-8. [PMID: 26903303 DOI: 10.1177/0148607116629673] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lara-Reyna S, Scambler T, Holbrook J, Wong C, Jarosz-Griffiths HH, Martinon F, Savic S, Peckham D, McDermott MF. Metabolic Reprograming of Cystic Fibrosis Macrophages via the IRE1α Arm of the Unfolded Protein Response Results in Exacerbated Inflammation. Front Immunol 2019;10:1789. [PMID: 31428093 DOI: 10.3389/fimmu.2019.01789] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
9 Sathe MN, Freeman AJ. Gastrointestinal, Pancreatic, and Hepatobiliary Manifestations of Cystic Fibrosis. Pediatr Clin North Am 2016;63:679-98. [PMID: 27469182 DOI: 10.1016/j.pcl.2016.04.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
10 Madzak A, Engjom T, Wathle GK, Olesen SS, Tjora E, Njølstad PR, Lærum BN, Drewes AM, Dimcevski G, Frøkjær JB, Haldorsen IS. Secretin-stimulated MRI assessment of exocrine pancreatic function in patients with cystic fibrosis and healthy controls. Abdom Radiol (NY) 2017;42:890-9. [PMID: 27832324 DOI: 10.1007/s00261-016-0972-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
11 Pfahler MHC, Kratzer W, Leichsenring M, Graeter T, Schmidt SA, Wendlik I, Lormes E, Schmidberger J, Fabricius D. Point shear wave elastography of the pancreas in patients with cystic fibrosis: a comparison with healthy controls. Abdom Radiol 2018;43:2384-90. [DOI: 10.1007/s00261-018-1479-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
12 Meyerholz DK. Lessons learned from the cystic fibrosis pig. Theriogenology 2016;86:427-32. [PMID: 27142487 DOI: 10.1016/j.theriogenology.2016.04.057] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
13 Balázs A, Mall MA. Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis. Front Pharmacol 2018;9:1112. [PMID: 30327603 DOI: 10.3389/fphar.2018.01112] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
14 Galante G, Freeman AJ. Gastrointestinal, Pancreatic, and Hepatic Manifestations of Cystic Fibrosis in the Newborn. Neoreviews 2019;20:e12-24. [PMID: 31261070 DOI: 10.1542/neo.20-1-e12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Semaniakou A, Croll RP, Chappe V. Animal Models in the Pathophysiology of Cystic Fibrosis. Front Pharmacol 2018;9:1475. [PMID: 30662403 DOI: 10.3389/fphar.2018.01475] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 17.0] [Reference Citation Analysis]
16 Giguere-Rich C, Mathew A, Reid E, Autore K, Guill MF. Use of an In-line Digestive Cartridge With Enteral Nutrition Improves the Weight Trajectory of 2 Children With Cystic Fibrosis Complicated by Another Medical Diagnosis. Nutr Clin Pract 2018;33:286-94. [PMID: 29658186 DOI: 10.1002/ncp.10080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Arends MJ, White ES, Whitelaw CB. Animal and cellular models of human disease. J Pathol 2016;238:137-40. [PMID: 26482929 DOI: 10.1002/path.4662] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
18 Vuurberg NE, Bakker I, van den Boom AL, de Haas RJ, Duiker EW, van den Heuvel MC, Klaase JM. Surgery for Ampullary Cancer in a Patient with Pancreatic Lipomatosis Caused by Cystic Fibrosis. Case Rep Gastroenterol 2020;14:695-701. [PMID: 33442351 DOI: 10.1159/000511129] [Reference Citation Analysis]
19 Marson FAL, Bertuzzo CS, de Araujo TK, Hortencio TDR, Ribeiro AF, Ribeiro JD. Pancreatic Insufficiency in Cystic Fibrosis: Influence of Inflammatory Response Genes. Pancreas 2018;47:99-109. [DOI: 10.1097/mpa.0000000000000963] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Schwimmer D, Glover S. Primary Immunodeficiency and the Gut. Gastroenterol Clin North Am 2019;48:199-220. [PMID: 31046971 DOI: 10.1016/j.gtc.2019.02.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
21 Ideozu JE, Zhang X, Pan A, Ashrafi Z, Woods KJ, Hessner MJ, Simpson P, Levy H. Increased Expression of Plasma-Induced ABCC1 mRNA in Cystic Fibrosis. Int J Mol Sci 2017;18:E1752. [PMID: 28800122 DOI: 10.3390/ijms18081752] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
22 Davies JC, Sermet-Gaudelus I, Naehrlich L, Harris RS, Campbell D, Ahluwalia N, Short C, Haseltine E, Panorchan P, Saunders C, Owen CA, Wainwright CE; VX16-661-115 Investigator Group. A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation. J Cyst Fibros 2021;20:68-77. [PMID: 32967799 DOI: 10.1016/j.jcf.2020.07.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
23 Sağlam D, Demirbaş F, Bilgici MC, Yücel S, Çaltepe G, Eren E. Can Point Shear Wave Elastography Be Used as an Early Indicator of Involvement?: Evaluation of the Pancreas and Liver in Children With Cystic Fibrosis. J Ultrasound Med 2020;39:1769-76. [PMID: 32309883 DOI: 10.1002/jum.15281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
24 Piskin FC, Yavuz S, Kose S, Cagli C, Dogruel D, Tumgor G, Aikimbaev K. A comparative study of the pancreas in pediatric patients with cystic fibrosis and healthy children using two-dimensional shear wave elastography. J Ultrasound 2020;23:535-42. [PMID: 32034705 DOI: 10.1007/s40477-020-00432-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
25 McCarron A, Cmielewski P, Reyne N, McIntyre C, Finnie J, Craig F, Rout-Pitt N, Delhove J, Schjenken JE, Chan HY, Boog B, Knight E, Gilmore RC, O'Neal WK, Boucher RC, Parsons D, Donnelley M. Phenotypic Characterization and Comparison of Cystic Fibrosis Rat Models Generated Using CRISPR/Cas9 Gene Editing. Am J Pathol 2020;190:977-93. [PMID: 32084371 DOI: 10.1016/j.ajpath.2020.01.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
26 Amato F, Castaldo A, Castaldo G, Cernera G, Corso G, Ferrari E, Gelzo M, Monzani R, Villella VR, Raia V. Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study. PLoS One 2021;16:e0245302. [PMID: 33412572 DOI: 10.1371/journal.pone.0245302] [Reference Citation Analysis]
27 Shei RJ, Mackintosh KA, Peabody Lever JE, McNarry MA, Krick S. Exercise Physiology Across the Lifespan in Cystic Fibrosis. Front Physiol 2019;10:1382. [PMID: 31780953 DOI: 10.3389/fphys.2019.01382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Faghih M, Garcia Gonzalez F, Makary MA, Singh VK. Total pancreatectomy for recurrent acute and chronic pancreatitis: a critical review of patient selection criteria. Curr Opin Gastroenterol 2017;33:330-8. [PMID: 28700371 DOI: 10.1097/MOG.0000000000000390] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
29 Zeng M, Vachel L, Muallem S. Physiology of Duct Cell Secretion. In: Beger HG, Warshaw AL, Hruban RH, Büchler MW, Lerch MM, Neoptolemos JP, Shimosegawa T, Whitcomb DC, Groß C, editors. The Pancreas. Chichester: John Wiley & Sons, Ltd; 2018. pp. 56-62. [DOI: 10.1002/9781119188421.ch5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Al-Selwi Y, Shaw JA, Kattner N. Understanding the Pancreatic Islet Microenvironment in Cystic Fibrosis and the Extrinsic Pathways Leading to Cystic Fibrosis Related Diabetes. Clin Med Insights Endocrinol Diabetes 2021;14:11795514211048813. [PMID: 34675737 DOI: 10.1177/11795514211048813] [Reference Citation Analysis]
31 Maiuri L, Villella VR, Piacentini M, Raia V, Kroemer G. Defective proteostasis in celiac disease as a new therapeutic target. Cell Death Dis 2019;10:114. [PMID: 30737369 DOI: 10.1038/s41419-019-1392-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
32 do Carmo TIT, Soares VEM, Wruck J, Dos Anjos F, de Resende E Silva DT, de Oliveira Maciel SFV, Bagatini MD. Hyperinflammation and airway surface liquid dehydration in cystic fibrosis: purinergic system as therapeutic target. Inflamm Res 2021;70:633-49. [PMID: 33904934 DOI: 10.1007/s00011-021-01464-z] [Reference Citation Analysis]
33 Gelzo M, Sica C, Elce A, Dello Russo A, Iacotucci P, Carnovale V, Raia V, Salvatore D, Corso G, Castaldo G. Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: a preliminary study of plasma sterols. Clin Chem Lab Med 2016;54:1461-6. [PMID: 26913457 DOI: 10.1515/cclm-2015-1151] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
34 Yoon JC. Evolving Mechanistic Views and Emerging Therapeutic Strategies for Cystic Fibrosis-Related Diabetes. J Endocr Soc 2017;1:1386-400. [PMID: 29264462 DOI: 10.1210/js.2017-00362] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
35 Lara-Reyna S, Holbrook J, Jarosz-Griffiths HH, Peckham D, McDermott MF. Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations. Cell Mol Life Sci 2020;77:4485-503. [PMID: 32367193 DOI: 10.1007/s00018-020-03540-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
36 Lamothe S, Zhang S. Chapter Five - Ubiquitination of Ion Channels and Transporters. Ubiquitination and Transmembrane Signaling. Elsevier; 2016. pp. 161-223. [DOI: 10.1016/bs.pmbts.2016.02.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
37 Bodewes F, Wilschanski M. CFTR Protein Function Modulation Therapy Is Finally Targeting Cystic Fibrosis-related Gastrointestinal Disease. J Pediatr Gastroenterol Nutr. 2018;66:372-373. [PMID: 29261530 DOI: 10.1097/mpg.0000000000001868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
38 Chiou J, Geusz RJ, Okino ML, Han JY, Miller M, Melton R, Beebe E, Benaglio P, Huang S, Korgaonkar K, Heller S, Kleger A, Preissl S, Gorkin DU, Sander M, Gaulton KJ. Interpreting type 1 diabetes risk with genetics and single-cell epigenomics. Nature 2021;594:398-402. [PMID: 34012112 DOI: 10.1038/s41586-021-03552-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
39 Coverstone AM, Ferkol TW. Early Diagnosis and Intervention in Cystic Fibrosis: Imagining the Unimaginable. Front Pediatr 2020;8:608821. [PMID: 33505947 DOI: 10.3389/fped.2020.608821] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Gelzo M, Iacotucci P, Sica C, Liguori R, Comegna M, Carnovale V, Dello Russo A, Corso G, Castaldo G. Influence of pancreatic status on circulating plasma sterols in patients with cystic fibrosis. Clin Chem Lab Med 2020;58:1725-30. [PMID: 32083440 DOI: 10.1515/cclm-2019-1112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
41 Christian F, Thierman A, Shirley E, Allen K, Cross C, Jones K. Sustained Glycemic Control With Ivacaftor in Cystic Fibrosis-Related Diabetes. J Investig Med High Impact Case Rep. 2019;7:2324709619842898. [PMID: 31010313 DOI: 10.1177/2324709619842898] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
42 Brinkmann F, Hanusch B, Ballmann M, Mayorandan S, Bollenbach A, Chobanyan-Jürgens K, Jansen K, Schmidt-Choudhury A, Derichs N, Tsikas D, Lücke T. Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results. J Clin Med 2020;9:E2012. [PMID: 32604946 DOI: 10.3390/jcm9062012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
43 Conese M, Beccia E, Castellani S, Di Gioia S, Colombo C, Angiolillo A, Carbone A. The long and winding road: stem cells for cystic fibrosis. Expert Opin Biol Ther 2018;18:281-92. [PMID: 29216777 DOI: 10.1080/14712598.2018.1413087] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
44 Semaniakou A, Chappe F, Anini Y, Chappe V. VIP reduction in the pancreas of F508del homozygous CF mice and early signs of Cystic Fibrosis Related Diabetes (CFRD). J Cyst Fibros 2021:S1569-1993(21)00133-8. [PMID: 34034984 DOI: 10.1016/j.jcf.2021.05.006] [Reference Citation Analysis]
45 Cios K, Cohen B, Quittell LM, Liu J, Larson EL. Impact of colonizing organism in the respiratory tract on the incidence, duration, and time between subsequent hospitalizations among patients with cystic fibrosis. Am J Infect Control 2019;47:750-4. [PMID: 30732978 DOI: 10.1016/j.ajic.2018.12.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
46 De Sutter P, Gasthuys E, Van Braeckel E, Schelstraete P, Van Biervliet S, Van Bocxlaer J, Vermeulen A. Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019. Clin Pharmacokinet 2020;59:1551-73. [DOI: 10.1007/s40262-020-00932-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Hart NJ, Aramandla R, Poffenberger G, Fayolle C, Thames AH, Bautista A, Spigelman AF, Babon JAB, DeNicola ME, Dadi PK, Bush WS, Balamurugan AN, Brissova M, Dai C, Prasad N, Bottino R, Jacobson DA, Drumm ML, Kent SC, MacDonald PE, Powers AC. Cystic fibrosis-related diabetes is caused by islet loss and inflammation. JCI Insight. 2018;3. [PMID: 29669939 DOI: 10.1172/jci.insight.98240] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 20.0] [Reference Citation Analysis]
48 Rotti PG, Xie W, Poudel A, Yi Y, Sun X, Tyler SR, Uc A, Norris AW, Hara M, Engelhardt JF, Gibson-Corley KN. Pancreatic and Islet Remodeling in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Knockout Ferrets. Am J Pathol 2018;188:876-90. [PMID: 29366680 DOI: 10.1016/j.ajpath.2017.12.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]